10-Q · 2026-11-06
Bitwise XRP ETF has filed its Q3 2026 financial results, showcasing its commitment to transparency in the cryptocurrency market.
| Name | Bitwise XRP ETF |
|---|---|
| CIK | 0002039525 |
| Tickers | XRP |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 6221 Commodity Contracts Brokers & Dealers |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 415-707-3663 |
| Website | — |
| Investor website | — |
| Owner org | 09 Crypto Assets |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Bitwise XRP ETF has filed its Q3 2026 financial results, showcasing its commitment to transparency in the cryptocurrency market.
20 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-06 | 10-Q | 10-Q | 0001193125-26-451776 | 001-42963 | 261531692 | 34 | 3990682 | 1 | 1 | |
| 2026-09-28 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003074 | 333-282465 | 261418950 | 33 | 1738 | ||
| 2026-09-28 | 424B3 | PROSPECTUS | 0001213900-26-104143 | 333-282465 | 261418189 | 33 | 1201821 | |||
| 2026-09-18 | POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 | 0001213900-26-101333 | 333-282465 | 261390493 | 33 | 1473457 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346245 | 001-42963 | 261266320 | 34 | 3930124 | 1 | 1 | |
| 2026-05-08 | 10-Q | 10-Q | 0001193125-26-214111 | 001-42963 | 26957402 | 34 | 3860143 | 1 | 1 | |
| 2026-03-27 | 424I | 424I | 0001193125-26-129356 | 333-282465 | 26808376 | 33 | 129991 | 1 | 1 | |
| 2026-03-20 | 10-K | 10-K | 0001193125-26-117414 | 001-42963 | 26777814 | 34 | 4342017 | 1 | 1 | |
| 2025-11-20 | 424B3 | PROSPECTUS | 0001213900-25-112749 | 333-282465 | 251500371 | 33 | 1147758 | |||
| 2025-11-20 | POS EX | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-112747 | 333-282465 | 251500365 | 33 | 312606 | |||
| 2025-11-19 | CERT | NYSE ARCA CERTIFICATION | 0001143362-25-000403 | 001-42963 | 251499066 | 34 | 383689 | |||
| 2025-11-19 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-112387 | 001-42963 | 251496975 | 34 | 34853 | |||
| 2025-10-31 | S-1/A | AMENDMENT NO. 4 TO FORM S-1 | 0001213900-25-104765 | 333-282465 | 251441481 | 33 | 3005960 | |||
| 2025-10-10 | CORRESP | filename1.htm | 0001213900-25-098174 | 60845 | ||||||
| 2025-10-10 | S-1/A | AMENDMENT NO. 3 TO FORM S-1 | 0001213900-25-098171 | 333-282465 | 251388634 | 33 | 1268940 | |||
| 2025-09-18 | UPLOAD | filename1.pdf | 0000000000-25-010192 | 333-282465 | 51720 | |||||
| 2025-08-22 | S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001213900-25-079990 | 333-282465 | 251247181 | 33 | 1368100 | 1 | 1 | |
| 2024-10-30 | UPLOAD | filename1.pdf | 0000000000-24-012109 | 333-282465 | 42630 | |||||
| 2024-10-16 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-24-088229 | 333-282465 | 241375414 | 33 | 1177850 | |||
| 2024-10-02 | S-1 | REGISTRATION STATEMENT | 0001213900-24-084334 | 333-282465 | 241345424 | 33 | 1236215 |
One latest value per concept from companyfacts (51 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 37.26M | 2026-11-01 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-20 | 0001193125-26-117414 | |
| us-gaap | Assets | Assets | USD | 615.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | AssetsHeldInTrust | Assets Held-in-trust | USD | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | AssetsNet | Net Assets | USD | 614.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 36.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 36.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | -38.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | IncreaseDecreaseInManagementAndIncentiveFeesPayable | IncreaseDecreaseInManagementAndIncentiveFeesPayable | USD | 127,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | IncreaseDecreaseInOperatingAssets | Increase (Decrease) in Operating Assets | USD | -38.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement | InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement | USD | 842,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyExpenseOffsetArrangement | Investment Company, Expense Offset Arrangement | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyExpenseRatioExcludingIncentiveFee | Investment Company, Expense Ratio Excluding Incentive Fee | pure | 0.003 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-214111 |
| us-gaap | InvestmentCompanyExpenseRatioIncludingIncentiveFee | Investment Company, Expense Ratio Including Incentive Fee | pure | 0.003 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyGainLossOnInvestmentPerShare | Investment Company, Gain (Loss) on Investment, Per Share | USD/shares | -3.8 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare | Investment Company, Investment Income (Loss) from Operations, Per Share | USD/shares | -3.84 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyInvestmentIncomeLossPerShare | Investment Company, Investment Income (Loss), Per Share | USD/shares | -0.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyInvestmentIncomeLossRatio | Investment Company, Investment Income (Loss) Ratio | pure | -0.003 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentCompanyTotalReturn | Investment Company, Total Return | pure | -0.188 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | -842,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | InvestmentOwnedAtCost | Investment Owned, at Cost | USD | 634.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | InvestmentOwnedAtFairValue | Investment Owned, at Fair Value | USD | 615.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | InvestmentOwnedPercentOfNetAssets | Investment Owned, Percent of Net Assets | pure | 1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | Liabilities | Liabilities | USD | 152,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | NetAssetValuePerShare | Net Asset Value Per Share | USD/shares | 16.62 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 256.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -256.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -38.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 842,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PartnersCapitalAccountPeriodIncreaseDecrease | Increase (Decrease) in Partners' Capital | USD | 412.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PartnersCapitalAccountRedemptions | Partners' Capital Account, Redemptions | USD | 66.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PartnersCapitalAccountSaleOfUnits | Partners' Capital Account, Sale of Units | USD | 478.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PartnersCapitalAccountUnitsPeriodIncreaseDecrease | Partners' Capital Account, Units, Period Increase (Decrease) | shares | 25.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PartnersCapitalAccountUnitsRedeemed | Partners' Capital Account, Units, Redeemed | shares | 4.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PartnersCapitalAccountUnitsSaleOfUnits | Partners' Capital Account, Units, Sale of Units | shares | 29.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PaymentsForPurchaseOfInvestmentOperatingActivity | PaymentsForPurchaseOfInvestmentOperatingActivity | USD | 314.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 62.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | ProceedsFromDispositionOfInvestmentOperatingActivity | ProceedsFromDispositionOfInvestmentOperatingActivity | USD | 58.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 319.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -38.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 1.489 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 | |
| us-gaap | SponsorFees | Sponsor Fees | USD | 842,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 6.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-451776 |